BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12792903)

  • 41. IL-7 and IL-7R in health and disease: An update through COVID times.
    Fernandes MB; Barata JT
    Adv Biol Regul; 2023 Jan; 87():100940. PubMed ID: 36503870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-7 receptor signaling network: an integrated systems perspective.
    Palmer MJ; Mahajan VS; Trajman LC; Irvine DJ; Lauffenburger DA; Chen J
    Cell Mol Immunol; 2008 Apr; 5(2):79-89. PubMed ID: 18445337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Therapeutic Values of IL-7/IL-7R and the Recombinant Derivatives in Glioma: A Narrative Review.
    Hesari M; Attar Z; Soltani-Shirazi S; Keshavarzian O; Taheri R; Tabrizi R; Fouladseresht H
    J Interferon Cytokine Res; 2023 Aug; 43(8):319-334. PubMed ID: 37566474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crystallization and preliminary X-ray diffraction of human interleukin-7 bound to unglycosylated and glycosylated forms of its alpha-receptor.
    Wickham J; Walsh ST
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Oct; 63(Pt 10):865-9. PubMed ID: 17909291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of IL-9 and STATs in hematological malignancies (Review).
    Chen N; Wang X
    Oncol Lett; 2014 Mar; 7(3):602-610. PubMed ID: 24520283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advances in IL-7 Research on Tumour Therapy.
    Fu C; Zhang X; Zhang X; Wang D; Han S; Ma Z
    Pharmaceuticals (Basel); 2024 Mar; 17(4):. PubMed ID: 38675377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer.
    Al-Rawi MA; Rmali K; Watkins G; Mansel RE; Jiang WG
    Eur J Cancer; 2004 Mar; 40(4):494-502. PubMed ID: 14962714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Role of IL-7 and IL-7R in Cancer Pathophysiology and Immunotherapy.
    Wang C; Kong L; Kim S; Lee S; Oh S; Jo S; Jang I; Kim TD
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma.
    Silva A; Almeida ARM; Cachucho A; Neto JL; Demeyer S; de Matos M; Hogan T; Li Y; Meijerink J; Cools J; Grosso AR; Seddon B; Barata JT
    Blood; 2021 Sep; 138(12):1040-1052. PubMed ID: 33970999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. COVID-19 and the role of cytokines in this disease.
    Hasanvand A
    Inflammopharmacology; 2022 Jun; 30(3):789-798. PubMed ID: 35505267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant.
    Bekele Y; Sui Y; Berzofsky JA
    Front Immunol; 2021; 12():737406. PubMed ID: 34603318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of Foxp3 and interleukin-7 receptor and clinicopathological characteristics of patients with diffuse large B-cell lymphoma.
    Zhao Y; Cui WL; Feng ZY; Xue J; Gulinaer A; Zhang W
    Oncol Lett; 2020 Apr; 19(4):2755-2764. PubMed ID: 32218828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Local and Systemic IL-7 Concentration in Gastrointestinal-Tract Cancers.
    Bednarz-Misa I; Diakowska D; Krzystek-Korpacka M
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31185636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update.
    Oliveira ML; Akkapeddi P; Ribeiro D; Melão A; Barata JT
    Adv Biol Regul; 2019 Jan; 71():88-96. PubMed ID: 30249539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. "Do We Know Jack" About JAK? A Closer Look at JAK/STAT Signaling Pathway.
    Bousoik E; Montazeri Aliabadi H
    Front Oncol; 2018; 8():287. PubMed ID: 30109213
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevated systemic interleukin-7 in patients with colorectal cancer and individuals at high risk of cancer: association with lymph node involvement and tumor location in the right colon.
    Krzystek-Korpacka M; Zawadzki M; Neubauer K; Bednarz-Misa I; Górska S; Wiśniewski J; Witkiewicz W; Gamian A
    Cancer Immunol Immunother; 2017 Feb; 66(2):171-179. PubMed ID: 27866242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-κB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells.
    Kong F; Hu W; Zhou K; Wei X; Kou Y; You H; Zheng K; Tang R
    J Exp Clin Cancer Res; 2016 Nov; 35(1):172. PubMed ID: 27821177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer Immunotherapy.
    Gao J; Zhao L; Wan YY; Zhu B
    Int J Mol Sci; 2015 May; 16(5):10267-80. PubMed ID: 25955647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-7 and interleukin-15 for cancer.
    Zarogoulidis P; Lampaki S; Yarmus L; Kioumis I; Pitsiou G; Katsikogiannis N; Hohenforst-Schmidt W; Li Q; Huang H; Sakkas A; Organtzis J; Sakkas L; Mpoukovinas I; Tsakiridis K; Lazaridis G; Syrigos K; Zarogoulidis K
    J Cancer; 2014; 5(9):765-73. PubMed ID: 25368677
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.